EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC)

Clinical trials for EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) explained in plain language.

Never miss a new study

Get alerted when new EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) trials appear

Sign up with your email to follow new studies for EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

First patients sought for groundbreaking engineered immune cell cancer trial

Disease control Not yet recruiting

This is the first study in people to test the safety and early effects of an experimental cell therapy called ML261. It is for adults with advanced small cell lung cancer or certain related neuroendocrine cancers that have come back or stopped responding to standard treatments. D…

Matched conditions: EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC)

Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC)

Get alerted when new EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC) trials appear

First patients sought for groundbreaking engineered immune cell cancer trial